Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
UXC | Ann: Removal from the Official List at Close of Trading | 29/02/16 | 0 | 1.6K | |||
|
|||||||
UXC | Ann: Implementation of Scheme of Arrangement | 29/02/16 | 0 | 1.3K | |||
|
|||||||
UXC | Ann: Ceasing to be a substantial holder | 17/02/16 | 0 | 950 | |||
|
|||||||
UXC | Ann: Becoming a substantial holder | 12/02/16 | 0 | 970 | |||
|
|||||||
UXC | Ann: Appendix 3B - Performance Rights | 12/02/16 | 0 | 1.4K | |||
|
|||||||
UXC | Ann: Suspension from Official Quotation - Close of Trading Today | 12/02/16 | 0 | 1.0K | |||
|
|||||||
UXC | News: UXC UXC says court approves scheme of arrangement | 11/02/16 | 0 | 1.0K | |||
|
|||||||
UXC | Ann: Court Approves Scheme of Arrangement | 11/02/16 | 0 | 852 | |||
|
See All Discussions